Abstract

The real-time drug-release monitoring is important for pharmacokinetic study toward clinical applications. The accuracy is usually severely affected by the fluctuation of complex biological microenvironment and dosage variation. Herein, a novel signal processor, upconversion nanoparticle (UCNP)-DNA nanocomplex (UCDC) was constructed via rational DNA design, enabling NIR-excited real-time in vivo drug-release monitoring, and realizing real-time pharmacokinetic monitoring. The signal processor was constructed by interfacial assembly of circular DNA on UCNP and the subsequent epitaxial assembly of ultralong DNA. Ultralong DNA chain was programed with multiple desired functional regions: double-stranded region for chemotherapy drugs integrating, DNA aptamer for tumor cells targeting and hairpin/i-motif switchable structure for tumor microenvironment responsive drug release. Based on filter effect of loaded drug molecules, efficient switch of real-time drug-release to optical signal was realized. For signal output, the ratiometer of red upconversion emission (UCLR) and NIR upconversion emission (UCLNIR) was monitored (UCLR/UCLNIR), with UCLNIR as an internal reference. In a breast cancer mouse model, the signal processor system achieved accurate and reliable localized drug-release monitoring, which effectively minimized the influence of the internal microenvironment and dosage variation.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.